Efficacy of an activity monitor as a biofeedback device in cerebral palsy.

ABSTRACT

BACKGROUND: Assessment of physical outcomes in patients with cerebral palsy (CP) is considered an effective way to monitor their progress, evaluate interventions and guide health care policy. However, no study using an activity monitor (AM) as a biofeedback device in treatment of people with CP has been published. Hence, the objective of this study was to evaluate the use of the AM as a biofeedback device in individuals with CP after a type of single-event multilevel surgery (SEMLS) called Single-Event Multilevel Lever Arm Restoration and Anti-Spasticity Surgery (SEMLARASS). METHOD: A randomized, controlled trial was conducted among 40 individuals with CP in the age group between 10 to 20 years who underwent SEMLARASS. They were randomly assigned to two groups Group A (n = 20) and Group B (n = 20). Both groups received intensive rehabilitation including different types of activity-based training for around three hours per day. Both groups were assessed with standard subjective outcomes (Physician Rating Scale (PRS), Dynamic Gait Index (DGI) and Functional Mobility Scale (FMS)) and objective outcomes with the use of an AM (IntenzLife, Model No. 56084-1) for measuring step count, distance walked and calories used. During the intervention, for Group A, they were also given an AM after presetting individualized stride length and body weight, to monitor their daily activity levels. The AM was worn around the neck of the person throughout the day and provided a daily report of the measurements and acted as a biofeedback device for individuals with CP who were given specific targets to achieve on a weekly basis. Both groups were evaluated before and after eight weeks of intensive rehabilitation. RESULTS: Group A showed significant differences in the scores of step count (p < 0.001), distance walked (p < 0.001), PRS (p < 0.001), DGI (p < 0.010) and FMS (p < 0.001) when compared to Group B after intensive rehabilitation. However, the calories used (p < 0.086) was not significantly different. CONCLUSION: The AM, which is considered to be a valid and reliable tool for assessing the level of physical activity in CP, can also be used as a biofeedback device for improving specific walking parameters in persons with CP post-SEMLARASS.